Potential Molecular Markers in Liver Cancer

Video

Anuradha S. Budhu, PhD, discusses using molecular features as predictive markers in liver cancer.

Anuradha S. Budhu, PhD, senior associate scientist, Laboratory of Human Carcinogenesis, program manager, Liver Cancer Program, Center for Cancer Research, National Cancer Institute, discusses using molecular features as predictive markers in liver cancer.

Genes are an important molecular feature that can shed light on individual biology, says Budhu. As such, investigators compare normally expressed genes with dysregulated or overexpressed genes to gain insight on cancer biology.

Other potential markers include microRNAs and downstream affecters of gene signaling such as metabolites and proteins, says Budhu.

By measuring the abundance of these features, investigators are aiming to understand tumor biology. These markers may help to identify liver cancer in patients, predict the aggressiveness of the disease, and determine which patients will benefit the most from treatment.

Related Videos
Video 9 - "FRESCO-2: Fruquintinib in Patients with Refractory Metastatic CRC"
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD